These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19262080)
1. [An experience of the use of Anti-HBc and Anti-HBs for blood donor screening tests at a tertiary hospital blood center in Korea]. Lim YA; Yoon S Korean J Lab Med; 2009 Feb; 29(1):59-65. PubMed ID: 19262080 [TBL] [Abstract][Full Text] [Related]
2. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion. Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Seo DH; Whang DH; Song EY; Kim HS; Park Q Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731 [TBL] [Abstract][Full Text] [Related]
4. Significance of isolated hepatitis B core antibody in blood donors. Schifman RB; Rivers SL; Sampliner RE; Krammes JE Arch Intern Med; 1993 Oct; 153(19):2261-6. PubMed ID: 8215729 [TBL] [Abstract][Full Text] [Related]
5. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Katz L; Strong DM; Tegtmeier G; Stramer S Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367 [TBL] [Abstract][Full Text] [Related]
6. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423 [TBL] [Abstract][Full Text] [Related]
7. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Muselmani W; Habbal W; Monem F Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787 [TBL] [Abstract][Full Text] [Related]
8. Community-based research: cost of the tests used for anti-HBc total seropositivity only and hepatitis B screening. Ozkan S; Atak A; Bozdayi G; Turkcuoglu S; Maral I Trans R Soc Trop Med Hyg; 2010 Dec; 104(12):782-6. PubMed ID: 20889180 [TBL] [Abstract][Full Text] [Related]
9. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay. O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210 [TBL] [Abstract][Full Text] [Related]
10. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [TBL] [Abstract][Full Text] [Related]
11. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country. van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685 [TBL] [Abstract][Full Text] [Related]
12. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [TBL] [Abstract][Full Text] [Related]
13. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677 [TBL] [Abstract][Full Text] [Related]
14. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [TBL] [Abstract][Full Text] [Related]
15. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening? Hourfar MK; Walch LA; Geusendam G; Dengler T; Janetzko K; Gubbe K; Frank K; Karl A; Löhr M; Sireis W; Seifried E; Schmidt M Int J Lab Hematol; 2009 Dec; 31(6):649-56. PubMed ID: 18673399 [TBL] [Abstract][Full Text] [Related]
17. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany. Houareau C; Offergeld R Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958 [TBL] [Abstract][Full Text] [Related]
18. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605 [TBL] [Abstract][Full Text] [Related]
20. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking]. Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]